EMERYVILLE, Calif., Nov. 28,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq:
AMRS), a leading synthetic biotechnology company accelerating the
world's transition to sustainable consumption through its
Lab-to-Market™ technology platform today announced record
consumer sales performance during this year's Black Friday sales
week from Friday, November 18 through
Saturday, November 26.
The beauty category, including cosmetics, skincare and haircare,
continues to demonstrate resilience and continued growth during the
current quarter and this year's holiday season. Amyris has seen new
record sales in its direct-to-consumer (DTC) channel and also
expects a strong showing from brick-and-mortar retail compared to
the year ago quarter with consumers returning to stores.
Biossance® is expected to achieve its first month of
$20 million in retail sales from a
combination of strong China Singles' Day (11/11), the largest
shopping day in the world, and Black Friday week. Biossance retail
sales represents external sales to consumers across physical retail
and online e-commerce channels, including Biossance's DTC channel.
The latter generated 76% of its November month to-date sales during
Black Friday week.
The next top three selling brands, after Biossance, grew their
combined DTC revenue more than 400% versus last year's Black Friday
week. These brands include JVN™ haircare, Rose
Inc.™ color cosmetics, and MenoLabs™ menopause
supplements.
"Consumer demand for clean, sustainable health and beauty
products continues to be strong. Our omnichannel strategy supports
this demand and the continued growth of our consumer brands," said
John Melo, President and Chief
Executive Officer. "Amyris consumer brands delivered record DTC
Black Friday week revenue which was 71% of November month to-date
DTC consumer revenue. Our DTC channels typically represent
approximately 45% of our total consumer revenue with 55% being
generated from brick-and-mortal retail. Besides our readiness for
the holiday shopping season, we continue to be very focused on
Barra Bonita's output to deliver our
strongest ingredient product revenue this quarter and on executing
the previously announced "Fit to Win" margin, cost and cash
actions."
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology
company, transitioning the Clean Health & Beauty and Flavors
& Fragrances markets to sustainable ingredients through
fermentation and the company's proprietary Lab-to-Market™
technology platform. This Amyris platform leverages
state-of-the-art machine learning, robotics and artificial
intelligence, enabling the company to rapidly bring new innovation
to market at commercial scale. Amyris ingredients are included in
over 20,000 products from the world's top brands, reaching more
than 300 million consumers. Amyris also owns and operates a family
of consumer brands that is constantly evolving to meet the growing
demand for sustainable, effective and accessible products. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo, Biossance, JVN, Lab-to-Market,
MenoLabs, and Rose Inc. are trademarks or registered trademarks of
Amyris, Inc. or its subsidiaries in the U.S. and/or other
countries.
Forward-Looking
Statements
This release contains forward-looking statements, and any
statements other than statements of historical fact could be deemed
to be forward-looking statements. These forward-looking statements
include, among other things, statements regarding future events,
such as Amyris' consumer sales and product revenue, including
Biossance retail sales, during Black Friday week, the month of
November 2022 and the fourth quarter
overall, and Amyris' expectations regarding its "Fit to Win"
initiatives and related impact to margin, cost and cash and its
financial performance for the remainder of 2022. These statements
are based on management's current expectations and actual results
and future events may differ materially due to risks and
uncertainties, including risks related to Amyris' liquidity and
ability to fund operating and capital expenses, risks related to
its financing activities, risks related to potential delays or
failures in completing and integrating planned acquisitions, risks
related to potential delays or failures in development, regulatory
approval, launch, production and commercialization of products,
risks related to global inflation and policy measures undertaken to
address inflation, the COVID-19 pandemic and any other geopolitical
events, including Russia's
invasion of Ukraine, resulting in
global economic, financial and supply chain disruptions that may
negatively impact Amyris' business operations and financial results
or cause market volatility, risks related to Amyris' reliance on
third parties particularly in the supply chain, and other risks
detailed from time to time in filings Amyris makes with the
Securities and Exchange Commission, including Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. Amyris disclaims any obligation to update information
contained in these forward-looking statements, whether as a result
of new information, future events, or otherwise.
View original
content:https://www.prnewswire.com/news-releases/amyris-consumer-brands-deliver-record-black-friday-week-sales-301687846.html
SOURCE Amyris, Inc.